The obligation to provide antiretroviral treatment in HIV prevention trials
Immune responses to abacavir in antigen-presenting cells from hypersensitive patients
Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma
High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis
HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1
The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years
Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort
Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adults
Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B
The role of compartment penetration in PI-Monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial
CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1
Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY)
The cost effectiveness of antiretroviral treatment strategies in resource-limited settings
Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening
‘Are you on the market?’: a capture–recapture enumeration of men who sell sex to men in and around Mombasa, Kenya
Drug-resistance surveillance among newly HIV-1 diagnosed individuals in Buenos Aires, Argentina
Men who have sex with men and their HIV epidemics in Africa
Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort
Transmission of multidrug-resistant HIV-1: 5 years of immunological and virological survey
Fosamprenavir/ritonavir plus tenofovir does not affect amprenavir pharmacokinetics: no effect of tenofovir
Cutaneous reactions with tenofovir disoproxil fumarate: a report of nine cases
Pharmacokinetics of once-daily tenofovir, emtricitabine, ritonavir and fosamprenavir in HIV-infected subjects
The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania
Effect of GB virus C co-infection on response to generic HAART in African patients with HIV-1 clade C infection
Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients
A child with HIV-associated transient cerebral arteriopathy
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption
Fatal myocardial co-infection by Toxoplasma gondii and Parvovirus B19 in an HIV patient
Successful long-course after failure of short-course desensitization in a patient with severe hypersensitivity reaction to enfuvirtide
Misleading results of screening for illicit drugs during efavirenz treatment
Alopecia associated with ritonavir-boosted atazanavir therapy
Efavirenz: innocent bystander or direct nephrotoxin?